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Abstract The excimer fluorescence from two pyrenyl moieties
attached to cysteines in human carbonic anhydrase II has been
monitored to characterize residual structure retained under
strong denaturing conditions. A position in L-strand 3, N67C,
together with the single naturally occurring cysteine 206 in L-
strand 7, were used as attachment sites. The eximer formation by
the pyrenyls, requiring proximity of the probes, revealed an
unfolding transition at a GuHCl concentration significantly
higher than that required to induce unfolding of the molten
globule state as monitored by CD. These results indicate that the
excimer transition monitors the unfolding of a residual compact
structure that spans L-strands 3^7. This region constitutes the
central and the most hydrophobic part of the molecule,
emphasizing the importance of hydrophobic interaction in
maintaining residual structure under strong unfolding conditions.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
We are using the enzyme human carbonic anhydrase II
(HCAII) as a model protein in our investigations of the pro-
tein folding mechanism [1]. The crystal structure of HCAII
has been determined at high resolution [2,3]. The active site
contains a zinc ion coordinated to three histidine residues.
The structure is illustrated schematically in Fig. 1. The overall
shape of the protein is ellipsoidal with the dimensions
39U42U55 Aî , and the molecular mass is 29 kDa. HCAII
consists of 10 L-strands connected by hairpin loops and
some helices. The open L-sheet stretches throughout the entire
molecule and divides it into two halves: the upper half in-
cludes the N-terminal helical region and the active site, and
the lower half contains a large hydrophobic core. This core
has previously been shown to be resistant to unfolding, even
at high concentrations of GuHCl [4,5].
Under moderate denaturing conditions, HCAII and mu-
tants thereof demonstrate characteristic features of a molten
globule state. The rate of alkylation of engineered cysteines
has revealed that some sulfhydryl groups are remarkably in-
accessible to alkylation, even at high (s 5 M) GuHCl concen-
trations [4,5]. This indicates that part of the protein structure,
i.e. L-strands 3^5, remains as a rather compact structure even
under strongly denaturing conditions. Residual structures
have also been detected in other proteins, that were previously
reported to be completely unfolded when examined by con-
ventional optical methods. By employing more speci¢c tech-
niques to study the unfolding process, for example NMR,
residual structure has been shown to persist in several proteins
[6^10]. Residual structure in the unfolded state has been re-
viewed [11], and has also been suggested to act as ‘seeds’ that
initiate the folding reaction [12]. Therefore, it is of great in-
terest to characterize such structures. We have initiated a ser-
ies of studies to map the topology and boundaries of residual
structures that exist at high denaturant concentrations. Obvi-
ously, it is of the utmost importance that a broad repertoire of
methods be developed that can give complementary structural
information. For this purpose, we introduce the use of pyrene
excimer £uorescence measurements in combination with site-
directed mutagenesis.
If two pyrenyl groups are close to each other (i.e. within a
few Aî ), they can form an excited state dimer (excimer) upon
excitation [13]. Compared to excited monomers, excimers pro-
duce a red-shifted spectrum. Consequently, excimer formation
is a versatile tool for probing rather short distances between
amino acid residues, and it gives information that comple-
ments energy transfer measurements, in which the probed
distances should, ideally, agree with the Foºrster radius (fre-
quently 30^100 Aî ).
In the experiments described here, we speci¢cally attached
pyrenyl £uorophores as proximity probes to a pair of cysteine
residues. The steric interference of the relatively bulky pyrenyl
moieties with the protein is of less signi¢cance in the unfolded
or partially folded states that we study in this report than in
the more compact native state. This method is therefore suit-
able for studies of conformational changes in the unfolded
state. Pyrene excimer £uorescence has previously been used
to study unfolding of the native state of tropomyosin [14]
and the distance between membrane-spanning helices [15].
2. Materials and methods
2.1. Materials
N-(1-pyrenemethyl)iodoacetamide, PMIA, was obtained from Mo-
lecular Probes. Sequential grade GuHCl was purchased from Pierce
and pure grade GuHCl was obtained from Merck. The GuHCl was
treated as described previously [4] and the concentrations were deter-
mined by refractive index [16].
2.2. Spectroscopic measurements
Fluorescence spectra were recorded on a Hitachi F-4500 £uorom-
eter equipped with a thermostated cell. The measurements were con-
ducted in 1 cm quartz cells at 23‡C with an excitation wavelength of
344 nm. Absorbance spectra were obtained with a Hitachi U-2000
spectrophotometer in 1 cm quartz cells. CD spectra were recorded
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on a CD6 spectrodichrograph (Jobin-Yvon Instruments SA), employ-
ing constant N2 £ushing.
2.3. Molecular modeling
Simulations of the mutation in HCAII were performed using the
computer program HyperChem (Hypercube Inc.). Molecular model-
ing of the N67C mutation was performed using the OPLS force ¢eld
[17] and a Polak Ribiere algorithm with 0.1 kcal/(Aî mol) as termina-
tion condition.
2.4. Production of mutated protein
Site-directed mutagenesis (N67C/C206), protein production and pu-
ri¢cation was performed as described previously [4,18,19]. C206 is the
unique cysteine in HCAII and is highlighted in this paper because it is
used as one of the attachment sites for a pyrene probe. Protein con-
centrations were determined from absorbance at 280 nm assuming the
extinction coe⁄cient of the mutant to be equivalent to the wild-type
protein O280 = 54 800 M31 cm31. Enzyme activity (CO2 hydration) was
measured as described elsewhere [20,21].
2.5. Stability measurements
The protein stability was determined using far-UV CD and £uores-
cence measurements. The protein was incubated prior to the measure-
ments for 24 h at 23‡C in various concentrations of GuHCl bu¡ered
with 0.1 M Tris-H2SO4, pH 7.5. Protein concentrations were 8.5 WM
(far-UV CD) and 0.85 WM (£uorescence).
2.6. Pyrene labeling
The N67C/C206 mutant was labeled in the unfolded state with
PMIA. Fifteen mg of protein was dissolved in 7.0 M GuHCl in
0.1 M Tris-H2SO4, pH 8.5 bu¡er and to prevent formation of disul-
¢de bridges a 2-fold molar excess of L-mercaptoethanol over protein
was added. 4.1 mg of PMIA was dissolved in 100 Wl of DMSO, and
was added in aliquots during mixing. The reaction mixture was left
for 24 h at 37‡C in the dark on a mechanical shaker. The reaction was
quenched by addition of 100 Wl of 0.2 M L-mercaptoethanol (2-fold
molar excess over PMIA) and centrifuged to remove precipitated re-
agent. The protein was refolded by dilution to 0.10 M GuHCl in 0.1 M
Tris-H2SO4, pH 7.5, with a protein concentration of 0.03 mg/ml. The
labeled protein was concentrated with Amicon YM-10 ¢lter and in a
Dia£o centriprep 10 (1100Ug, 30 min) to 2 ml. The turbid solution
was ¢ltered and gel ¢ltrated. The gel ¢ltration was performed on a
Sephadex G-25 column (coarse gel ; Pharmacia) equilibrated with
10 mM Na-borate bu¡er, pH 7.5.
2.7. Determination of the degree of labeling
The concentration of the PMIA adduct was determined spectropho-
tometrically, using O344 = 41 000 M31 cm31 [22]. The protein concen-
tration was determined at 280 nm after subtraction of the absorbance
of the probe.
3. Results
HCAII has one naturally occurring cysteine residue, C206,
which is located in L-strand 7. C206 was used as one of the
attachment sites for the pyrene moiety and the engineered
N67C, in L-strand 3, as the other attachment site. Computer
modeling showed an angle between the side chains C67 and
C206 (CL-S) of 60‡ and a sulfur-sulfur distance of 15 Aî , which
indicated that attachments to these sites would be favorable
for formation of excimers.
3.1. Characterization of the N67C/C206 mutant
A speci¢c enzymatic activity of 88% for the N67C/C206
mutant (CO2 hydration activity) was retained as compared
to the wild-type enzyme. Since the activity of an enzyme is
very sensitive to structural alterations, and because the activ-
ity of the studied mutant was almost intact, it is not likely that
the mutation caused any major conformational changes. Fur-
thermore, the midpoint concentrations of denaturation are
very similar to the wild-type HCAII (0.9 M and 2.3 M GuHCl
(data not shown) for the nativeCmolten globule state and
molten globuleCunfolded state transition, respectively).
3.2. Incorporation of label
During the labeling procedure, a high concentration of
GuHCl was used due to the di⁄culty of gaining access to
the cysteines 67, and 206 [5]. The degree of labeling of the
N67C/C206 mutant was found to be 1.8^2.0 pyrenes per pro-
tein molecule in 3 di¡erent labeling experiments. 10% of the
enzymatic activity was regained when py-N67C/C206-py was
subjected to conditions favoring the native state. This recov-
FEBS 19636 17-12-97
Fig. 1. Schematic view of the polypeptide backbone of human carbonic anhydrase II with the mutated and labeled sites indicated. Picture
drawn using the program MOLSCRIPT [32].
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ery of activity could possibly be due to a small fraction of
unlabeled enzyme. The low degree of reactivation of the modi-
¢ed enzyme is not unexpected, since interference with the
formation of the vicinal active site is likely to occur. Since
we are primarily interested in the conformations of residual
structures that are present under strong denaturing conditions
in the unfolded state, perturbation of the native state is of less
signi¢cance.
3.3. CD measurements
The near-UV CD spectrum in Fig. 2b shows py-N67C/
C206-py and as a comparison the spectrum of HCAII is
also included. This CD spectrum of py-N67C/C206-py has
clear interferences from the pyrene moieties with distinct
peaks at 247 nm and 278 nm, but is otherwise similar to the
HCAII near-UV spectrum. This indicates that py-N67C/
C206-py has folded into a native-like tertiary structure [18].
CD measurements in the far-UV wavelength region, Fig. 2a,
display a di¡erent spectrum than that of the unlabeled
HCAII, presumably due to contribution from the pyrenyl
moieties. Nevertheless, changes in the CD signal at 222 nm
were considered to re£ect changes in secondary structure.
After incubation of py-N67C/C206-py in various concentra-
tions of GuHCl, the mean residue ellipticity at 222 nm was
monitored and plotted versus GuHCl concentration in Fig. 3.
Between 0^1 M GuHCl a decrease in ellipticity was recorded,
due to loss of contribution from tryptophan residues [18],
when transition to the molten globule state occurs ([4], Kris-
tina BoreŁn, personal communication). Thus, the native state
appears to be somewhat destabilized because of steric inter-
ferences from the pyrene groups (Fig. 3). In the interval
1.7^3.5 M GuHCl an increase was detected. The second CD
transition is indicative of loss of secondary structure. Curve
¢tting was performed between 1.2^5.5 M GuHCl, for the data
in Fig. 3. The midpoint concentration of transition was at 2.8
M GuHCl, which is at higher GuHCl concentrations than the
corresponding transition of the unlabeled protein (2.3 M)
which was monitored by Trp £uorescence. This could indicate
that the molten globule state is stabilized by the pyrene moi-
eties. The stabilization is probably not due to strong interac-
tions between the two pyrene probes (see Section 3.5), but it is
possible that the attached hydrophobic pyrene groups are lo-
cated in the protein interior and thus contribute to the stabil-
ity of the molten globule state. A similar e¡ect was previously
observed for a L118C substitution in HCAII [4], where the
removal of a hydrophobic leucine in the protein core destabi-
lized the molten globule state. Another possibility is that the
observed di¡erence could be due to spectroscopic interference
from the pyrene moieties.
3.4. Fluorescence emission spectra
Fig. 4a shows the £uorescence emission spectrum of pyren-
yl-labeled L-mercaptoethanol (py-L-merc). The spectrum is
typical of a monomeric pyrenyl. Fig. 4b shows the £uores-
cence spectra of py-N67C/C206-py in presence and absence
of GuHCl. The spectra exhibit a broad structureless band
centered at 460^480 nm at low and intermediate concentra-
tions of GuHCl. This band is diagnostic for an excimer
formed from pyrenyl probes [23]. The excimer emission peak
is around 465 nm, which shows that the probes are in an
apolar environment [24]. The excimer band disappears at
high concentrations of GuHCl.
3.5. Excitation spectra
Excitation spectra were recorded to investigate whether
ground state interactions occurred between the pyrenyl
probes. Excitation spectra were recorded at 280^360 nm for
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Fig. 2. CD spectra of py-N67C/C206-py (999) and HCAII (^ ^ ^).
The mean residue ellipticity was measured. a: Far-UV spectra re-
corded in a 0.1 mm cuvette with a protein concentration of 17 WM
in 10 mM Na-borate bu¡er pH 7.5. b: Near-UV spectra recorded
in a 0.5 cm cuvette with conditions as in a.
Fig. 3. Unfolding of py-N67C/C206-py monitored by change in
mean residue ellipticity at 222 nm. Protein concentration was 8.5 WM
in varying concentrations of GuHCl and 0.1 M Tris-H2SO4, pH 7.5
in a 0.5 mm cuvette.
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py-N67C/C206-py. The pyrene emission was monitored at
both 379 and 460 nm to detect the £uorescence from excited
monomeric pyrene and that from excimers [25]. The two
excitation pectra di¡er, and the peaks of the spectra detected
at 460 nm, i.e. excimer £uorescence, are red-shifted and
slightly broadened, as compared to the peaks of the spectra
detected at 379 nm, i.e. monomer £uorescence (data not
shown). The di¡erence between the spectra indicates that pyr-
ene moieties that form excimers had already formed dimers
prior to excitation, or that these moieties were in a di¡erent
environment than the non-excimer-forming pyrenyl moieties
were. This is a ubiquitous feature of the formation of excimers
from pyrenyls attached to proteins in aqueous solution [23].
Studies of the time dependence of the excimer £uorescence
have shown that there is no build-up phase verifying that
the excimers are formed from ground state complexes of pyr-
ene [26]. Despite the possibility of ground state interaction
between the probes, it is highly probable that the interaction
is weak. Di¡erent pyrenyl-labeled proteins vary greatly in re-
gard to the GuHCl concentration at which excimer £uores-
cence disappears [14,27], which strongly implies that the di-
merization of pyrene in the ground state has no major e¡ect
on protein denaturation. However, the introduction of hydro-
phobic groups like pyrenes can a¡ect the stability of a protein
as discussed above.
3.6. GuHCl-induced unfolding monitored by pyrene excimer
£uorescence
The £uorescence from pyrene excimers was monitored in
the range 440^550 nm. A transition curve was obtained for
py-N67C/C206-py after incubation in various concentrations
of GuHCl by plotting the excimer emission intensity versus
GuHCl concentration (Fig. 5). Essentially an identical transi-
tion curve was obtained when the protein was unfolded in 6 M
GuHCl and then diluted to lower GuHCl concentrations,
showing that the unfolding (folding) reaction is reversible in
the GuHCl concentration range 2.5^6 M.
3.7. GuHCl-induced unfolding monitored by pyrene monomer
£uorescence
The pyrene monomer £uorescence was also monitored (Fig.
5). The monomer £uorescence continues to increase at con-
centrations of GuHCl above 4 M, where the excimer £uores-
cence has disappeared. Since the pyrene monomer £uores-
cence intensity (at 379 nm) of a pyrene L-mercaptoethanol
adduct is independent of GuHCl concentration (data not
shown) the increase in monomer £uorescence is an inherent
feature for the py-N67C/C206-py molecule. This observed
variation indicates a change in the environment surrounding
the probes. It is likely that the monomer £uorescence in-
creases as the excimers are separated, i.e. the concentration
of the monomers increases, and it might also re£ect loss of
quenching from charged residues in the folded state of the
protein. This could indicate that the pyrene moieties are
quenched in 4 M GuHCl but as the protein is further un-
folded in the interval 4^7 M GuHCl this quenching decreases.
In a complementing experiment py-N67C/C206-py was frag-
mented with trypsin. Several Lys and Arg residues, where
trypsin cleaves the polypeptide, are present in the sequence.
One sample was pretreated with trypsin for 1 h and then
solvated in 4.5 M GuHCl, and another sample was solvated
in 4.5 M GuHCl without protease treatment. The trypsin-
treated sample had 30% higher monomer £uorescence inten-
sity than the uncleaved sample. This indicates that the envi-
ronment quenching the pyrene £uorescence is partly de-
stroyed. The quenching might originate from closely located
charged residues.
4. Discussion
Under strong denaturing conditions we have earlier ob-
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Fig. 4. Selected pyrenyl £uorescence emission spectra. a: Emission
from pyrenyl-labeled L-mercaptoethanol (2 WM) is shown. b: Emis-
sion from py-N67C/C206-py in 0.0 M (999), 3.0 M (^ ^ ^) and
5.1 M (- - -) GuHCl. Excitation was performed at 344 nm with
5 nm excitation and 2.5 nm emission slits in all measurements. Pro-
tein concentrations were 2 WM and bu¡ered by 0.1 M Tris-H2SO4,
pH 7.5.
Fig. 5. Unfolding transition curves for py-N67C/C206-py as moni-
tored by pyrene £uorescence. Monomer £uorescence intensity (a)
recorded at 379 nm and excimer £uorescence intensity (b) recorded
at 465 nm. (Lines drawn to guide the eye.)
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served residual structure in HCAII that persists after the mol-
ten globuleCunfolded state transition [4,5]. In the present
study we have further explored the borders of this residual
structure by labeling L-strands 3 and 7 of the protein with two
pyrenyl moieties, which are used as proximity probes through
their ability to form excimers.
Excimer formation has distinct geometric requirements and
is therefore a versatile tool for studying unfolding. As long as
two pyrenenyl moieties, attached to a protein, are within a few
Aî distance an excimer band can be seen in the £uorescence
spectrum. Extensive unfolding of the protein would separate
the sites and the band would disappear. In order to prevent
excimer formation due to local interactions we chose attach-
ment sites which had close proximity in the native state and
were well separated in the primary sequence.
Py-N67C/C206-py displayed excimer £uorescence in the
folded state, and raising the concentration of GuHCl made
the excimer £uorescence increase in the interval 0^1.7 M
GuHCl with a plateau between 1.7^3 M GuHCl followed
by a sharp decrease above 3 M. The band had virtually dis-
appeared at 4 M GuHCl. Thus, the favorable excimer inter-
action that is observed between 1.7 and 3 M GuHCl (Fig. 5)
indicates that a compact structure persists at these denaturant
concentrations. The disruption of the residual structure at
higher GuHCl concentrations is shown by the loss of excimer
formation with a transition midpoint at 3.4 M GuHCl (Fig. 5).
As comparison the unfolding of py-N67C/C206-py monitored
by far-UV CD at 222 nm shows a transition midpoint at 2.8
M GuHCl for unfolding of secondary structure (Fig. 3). We
can conclude from our experiments that a compact structure
is preserved between L-strands 3 and 7, which constitute the
central part of the molecule. Our earlier experiments have
shown that single amino acid residues in L-strands 3^5 are
inaccessible to alkylation until the concentration of GuHCl
is raised to about 5 M, which indicates the existence of a
compact residual structure under these strongly denaturing
conditions [4,5]. However, Cys-206 in L-strand 7 does become
accessible for alkylation during the molten globuleCunfolded
state transition, with a midpoint concentration of 2.5 M
GuHCl. In the present investigation it was clear that this
L-strand is also held together with the region consisting of
L-strands 3^5. L-strand 7 most likely forms one of the borders
of the stable residual structure. L-strands 3^5 are included in
the large hydrophobic cluster in the major domain of HCAII,
and L-strands 6^7 constitute the most hydrophobic stretches
in the molecule [28]. In other proteins residual structure under
strongly denaturing conditions has also been detected [6^10].
It has been pointed out that continuous strings of non-polar
side chains, which are present in the proteins mentioned above
as well as in HCAII, could nucleate the formation of hydro-
phobic clusters [10]. From immobilization of a spin-label dur-
ing refolding of spin-labeled HCAII [29], we suggested in 1975
that hydrophobic L-strands might act as a folding initiation
site in HCAII. Others have also hypothesized that stretches of
apolar side chains can act as chain folding initiation sites [30].
Furthermore, in this study we detect a compact state that
appears to remain at very high concentrations of GuHCl.
The increase in monomer £uorescence indicates that the envi-
ronment surrounding the pyrenes is further changed in the
4^7 M GuHCl range. The detected quenching would require
a compact structure, irrespective of the nature of the quench-
ing, at very high concentrations of GuHCl. Since no plateau
value is reached this compact unfolded state is preserved up to
7 M GuHCl.
The residual structure appears to have considerable £exibil-
ity, since according to an earlier study of Trp £uorescence [19]
all Trp residues were exposed to solvent at 3 M GuHCl. In
addition, a recent kinetic study [31] of refolding from 3.3 M
GuHCl solutions indicated that Trp-97 situated in L-strand 4
becomes buried in a native-like environment within a 2 ms
burst phase. Apparently, the residual structure can rearrange
into a compact and rigid form very rapidly.
We can conclude that pyrene excimer £uorescence measure-
ments provide structural information which complements that
gained by chemical reactivity measurements and the use of
single spectroscopic probes. The excimer approach is partic-
ularly suitable for probing compactness in extensively dena-
tured proteins, i.e. for identifying residual structures. That is
because the probes must be brought together in the 3-D struc-
ture to allow excimer formation from two £uorophores linked
to the polypeptide chain. We will continue to map the boun-
daries of the residual structures by pyrene probing.
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